- Home
- SBFM vs MATH Comparison
SBFM vs MATH Comparison
Compare SBFM & MATH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SBFM
- MATH
- Stock Information
- Founded
- SBFM 2006
- MATH 2015
- Country
- SBFM United States
- MATH Hong Kong
- Employees
- SBFM N/A
- MATH N/A
- Industry
- SBFM Biotechnology: Pharmaceutical Preparations
- MATH Finance/Investors Services
- Sector
- SBFM Health Care
- MATH Finance
- Exchange
- SBFM Nasdaq
- MATH Nasdaq
- Market Cap
- SBFM 4.9M
- MATH 60.8M
- IPO Year
- SBFM N/A
- MATH N/A
- Fundamental
- Price
- SBFM $1.35
- MATH $1.67
- Analyst Decision
- SBFM Strong Buy
- MATH
- Analyst Count
- SBFM 1
- MATH 0
- Target Price
- SBFM $15.00
- MATH N/A
- AVG Volume (30 Days)
- SBFM 4.3M
- MATH 50.1K
- Earning Date
- SBFM 05-19-2025
- MATH 10-31-2024
- Dividend Yield
- SBFM N/A
- MATH N/A
- EPS Growth
- SBFM N/A
- MATH N/A
- EPS
- SBFM N/A
- MATH 0.17
- Revenue
- SBFM $34,874,283.00
- MATH $31,399,049.00
- Revenue This Year
- SBFM $192.48
- MATH N/A
- Revenue Next Year
- SBFM N/A
- MATH N/A
- P/E Ratio
- SBFM N/A
- MATH $9.77
- Revenue Growth
- SBFM 44.75
- MATH 291.58
- 52 Week Low
- SBFM $1.17
- MATH $0.80
- 52 Week High
- SBFM $33.60
- MATH $2.78
- Technical
- Relative Strength Index (RSI)
- SBFM 34.08
- MATH 51.63
- Support Level
- SBFM $1.17
- MATH $1.52
- Resistance Level
- SBFM $1.59
- MATH $1.70
- Average True Range (ATR)
- SBFM 0.33
- MATH 0.14
- MACD
- SBFM -0.01
- MATH 0.01
- Stochastic Oscillator
- SBFM 6.63
- MATH 65.72
About SBFM Sunshine Biopharma Inc.
Sunshine Biopharma Inc is a pharmaceutical company offering and researching life-saving medicines in a wide variety of therapeutic areas, including oncology and antivirals. Through its subsidiaries, the company has various generic prescription drugs on the market in Canada and is also involved in developing and selling OTC supplements. In addition, the company is conducting a proprietary drug development program, which is comprised of K1.1 mRNA targeted for liver cancer and SBFM-PL4, PLpro protease inhibitor for SARS Coronavirus infections.
About MATH Metalpha Technology Holding Limited
Metalpha Technology Holding Ltd is a digital asset focused wealth management company. The company predominantly generates revenue from the execution of cryptocurrency-related transactions, which includes the issuance of derivative products to over-the-counter (OTC) clients and its proprietary trading activities. It has partnered with a crypto exchange to provide crypto derivative market-making services for its clients, facilitating the trading of crypto derivative products. In addition, the company also engages in providing traditional financial derivative products, and asset management services. It operates in a single segment which is the trading of proprietary digital assets and derivative contracts, and derives a majority of its revenue from Hong Kong.